Belimumab therapy for systemic lupus erythematosus and potential treatment of rheumatoid arthritis

Changhai Ding, Ran Li, Jianhua Xu, Flavia Cicuttini, Graeme Jones

Research output: Contribution to journalArticleResearchpeer-review


B-lymphocyte stimulator (BLyS) maintains the survival of B cells, and is elevated in serum or locally in patients with systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA).
Original languageEnglish
Pages (from-to)623 - 633
Number of pages11
JournalDrug Development Research
Issue number7
Publication statusPublished - 2011

Cite this